(2-Methoxyethoxy)acetic acid: a urinary biomarker of exposure for jet fuel JP-8

  • Clayton B’Hymer
  • Patricia Mathias
  • Edward KriegJr.
  • Kenneth L. Cheever
  • Christine A. Toennis
  • John C. Clark
  • James S. Kesner
  • Roger L. Gibson
  • Mary Ann Butler
Original Article



To demonstrate the utility of the urinary metabolite (2-methoxyethoxy)acetic acid (MEAA) as a biomarker of exposure. 2-(2-methoxyethoxy)ethanol [diethylene glycol monomethyl ether] is an anti-icing agent used in the formulation of JP-8, and it is added at a known uniform 0.1% (v/v) concentration to each batch lot. JP-8 is a kerosene-based fuel containing different compounds that vary in the content of every batch/lot of fuel; thus, MEAA has the potential to be a more specific and a consistent quantitative biomarker for JP-8 exposure.


MEAA was used to measure exposure of jet propulsion fuel 8 (JP-8) in United States Air Force (USAF) personnel working at six airbases within the United States. Post-shift urine specimens from various personnel including high (n = 98), moderate (n = 38), and low (n = 61) exposure workgroup categories were collected and analyzed by a gas chromatographic-mass spectrometric test method. The three exposure groups were evaluated for the number per group positive for MEAA, and a statistical analysis consisted of pair-wise t-tests for unequal variances was used to test for the differences in mean MEAA concentrations between the exposure groups.


The number of samples detected as positive for MEAA exposure, that is, those above the test method’s limit of detection (LOD = 0.1 μg/ml), were 92 (93.9%), 13 (34.2%), and 2 (3.3%) for the high, moderate, and low exposure workgroup categories, respectively. The mean urinary MEAA level was significantly greater in the high exposure category (6.8 μg/ml), compared to the moderate (0.42 μg/ml) and the low (0.07 μg/ml) exposure categories. The maximum concentration of urinary MEAA was 110 μg/ml for the high exposure category, while 4.8 μg/ml and 0.2 μg/ml maximum levels were found in the moderate and low exposure categories, respectively.


This study demonstrated that urinary MEAA can be used as an accurate biomarker of exposure for JP-8 workers and clearly distinguished the differences in JP-8 exposure by workgroup category.


Urinary biomarkers Jet propulsion fuel 8 JP-8 (2-methoxyethoxy)acetic acid MEAA 


  1. Alessio L, Berlin A, Dell’Orto A, Toffoletto F, Chezzi I (1985) Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Env Health 55:99–106CrossRefGoogle Scholar
  2. ATSDR (1998) Toxicological profile for jet fuels (JP-5 and JP-8). U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia:Google Scholar
  3. B’Hymer C, Cheever KL (2010) Biomarkers and metabolites: HPLC/MS analysis. In: Cazes J (ed) Encyclopedia of chromatography, 3rd edn. CRC Press/Taylor & Francis, Boca Rotan, Florida, pp 238–246Google Scholar
  4. B’Hymer C, Cheever KL, Butler MA, Brown KK (2003) Procedure for the quantification of the biomarker (2-methoxethoxy)acetic acid in human urine. J Chromatogr A 795:145–150Google Scholar
  5. B’Hymer C, Butler MA, Cheever KL (2005a) A comparison and evaluation of analysis procedures for the quantification of (2-methoxyethoxy)acetic acid in urine. Anal Bioanal Chem 383:201–209CrossRefGoogle Scholar
  6. B’Hymer C, Keil DE, Cheever KL (2005b) A test procedure for the determination of (2-methoxyethoxy)acetic acid in urine from jet fuel-exposed mice. Toxicol Mech Methods 15:367–373CrossRefGoogle Scholar
  7. Baker W, Miller T, Dodd D, McDougal J. (1999) Repeated dose skin irritation study on jet fuels—a histopathology study. Operational Toxicology Branch, Wright-Patterson AFB, OHIO, AFRl-HE-WP-TR-1999-022Google Scholar
  8. Boeniger MF, Lowry LK, Rosenberg J (1993) Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 54:615–627CrossRefGoogle Scholar
  9. Brown KK, Cheever KL, Butler MA, Shaw P, McLaurin JL (2003) Synthesis, characterization and use of 2-[(2H9)butoxy]acetic acid and 2-(3-methylbutoxy)acetic acid as an internal standard and instrument performance surrogate, respectively, for the gas chromatographic-mass spectrometric determination of 2-butoxyacetic acid, a human metabolite of 2-butroxyethanol. J Chromatogr B 792:150–159CrossRefGoogle Scholar
  10. Carrieri M, Tevisan A, Bartolucci GB (2001) Adjustment to concentration-dilution of spot urine samples: correlation between specific gravity and creatinine. Int Arch Occup Env Health 74:63–67CrossRefGoogle Scholar
  11. Chao YE, Nylander-French LA (2004) Determination of keratin protein in a tape-stripped skin sample from jet fuel exposed skin. Ann Occup Hyg 48:65–73CrossRefGoogle Scholar
  12. Chao YE, Gibson RL, Nylander-French LA (2005) Dermal exposure to jet fuel (JP-8) in U.S. Air Force personnel. Ann Occup Hyg 49:639–645CrossRefGoogle Scholar
  13. Chao YE, Kupper LK, Serdar B, Egeghy PP, Rappaport SM, Nylander-French LA (2006) Dermal exposure to jet fuel JP-8 significantly contributes to the production of urinary naphthols in fuel-cell maintenance workers. Environ Health Perspect 114:182–185CrossRefGoogle Scholar
  14. Cheever KL, Richards DL, Weigel WW, Lal JB, Dinsmore AM, Daniel FB (1988) Metabolism of bis(2-methoxethyl)ether in the adult male rat–evaluation of the principle metabolite as a testicular toxicant. Toxicol Appl Pharmacol 94:150–159CrossRefGoogle Scholar
  15. Cochran WG, Cox GM (1950) Experimental designs. Wiley, New YorkGoogle Scholar
  16. Daniel FB, Cheever KL, Begley KB, Richards DE, Weigel WW (1991) Bis(2-methoxyethyl) ether: metabolism and embryonic disposition of a development toxicant in the pregnant CD-1 mouse. Fundam Appl Toxicol 16:567–575CrossRefGoogle Scholar
  17. Egeghy PP, Hauf-Cabalo L, Gibson RL, Rappaport SM (2003) Benzene and naphthalene in air and breath as indicators of exposure to jet fuel. Occup Environ Med 60:969–976CrossRefGoogle Scholar
  18. Findlay JB, Wu AL, Knott V, Mauck L, Frickey PH, Norton GE (1985) Development of a Kodak Ektachem® clinical chemistry slide for CK-B activity. Clin Chem 31(Abstract 509):1000Google Scholar
  19. Gaines LGT, Fent KW, Flack SL, Thomasen JM, Ball LM, Zhou H, Whittaker SG, Nylander-French LA (2010) Effect of creatinine and specific gravity normalization on urinary biomarker 1, 6-hexamethylene diamine. J Environ Monit 12:591–599CrossRefGoogle Scholar
  20. Helsel D (2010) Much ado about next to nothing: Incorporating nondetects in science. Ann Occup Hyg 54:257–262CrossRefGoogle Scholar
  21. Hornung RW, Reed LD (1990) Estimation of average concentration in the presence of non-detectable values. Appl Occup Environ Hyg 5:46–51CrossRefGoogle Scholar
  22. Kim D, Anderson ME, Nylander-French LA (2006) Dermal absorption and penetration of jet fuel component in humans. Toxicol Lett 165:11–21CrossRefGoogle Scholar
  23. Knave B, Olsen BA, Elofsson S, Gamberale F, Isaksson A, Mindus P, Persson HE, Struwe G, Wennberg A, Westerholm P (1978) Long-term exposure to jet fuel. II. A cross-sectional epidemiologic investigation on occupationally exposed industrial workers with special reference to the nervous system. Scand J Work Environ Health 4:19–45CrossRefGoogle Scholar
  24. Li Y, Li AC, Shi H, Junga H, Jiang H, Jiang X, Naidong W, Lauterbach JH (2006) Determination of S-phenylmercapturic acid in human urine using an automated sample extraction and fast liquid chromatography-tandem mass spectrometry method. Biomed Chromatogra 20:597–604CrossRefGoogle Scholar
  25. Maestri L, Negri S, Ferrari M, Ghittori S, Imbriani M (2005) Determination of urinary S-phenylmercapturic acid as a specific metabolite of benzene by liquid chromatography/single quadrupole mass spectrometry. Rapid Commun Mass Spectrom; 19:1139–1144CrossRefGoogle Scholar
  26. Manini P, Andreoli R, Mutti A (2006) Application of liquid chromatography-mass spectrometery to biomonitoring of exposure to industrial chemicals. Toxicol Lett; 162:202–210CrossRefGoogle Scholar
  27. Marchese S, Cruini R, Gentili A, Perret D, Rocca LM (2004) Simultaneous determination of urinary metabolites of benzene, toluene, xylene and styrene using high-performance liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 18:265–272CrossRefGoogle Scholar
  28. Mattie DR, Sterner TR (2011) Past, present and emerging toxicity issues for jet fuel. Toxicol Appl Pharmacol (article in press)Google Scholar
  29. Mattorano DA, Kupper LL, Nylander-French LA (2004) Estimating dermal exposure to jet fuel (naphthalene) using adhesive tape strip samples. Ann Occup Hyg 48:139–146CrossRefGoogle Scholar
  30. Mauck JC, Mauck L, Novros J, Norton GE, Toffaletti J (1986) Development of a single slide Kodak Ektachem® thin-film assay for serum and urine creatinine. Clin Chem 32(Abstract 735):1197–1198Google Scholar
  31. McDougal JN, Rogers JV (2004) Local and systemic toxicity of JP-8 from cutaneous exposures. Toxicol Lett 149:301–308CrossRefGoogle Scholar
  32. McDougal JN, Pollard DL, Weisman W, Garrett CM, Miller TE (2000) Assessment of skin absorption and penetration of JP-8 jet fuel and its components. Toxicol Sci 55:247–255CrossRefGoogle Scholar
  33. NRC (2003) Toxicologic assessment of jet-propulsion fuel 8. National Research Council of the National Academies. The National Academies Press, WashingtonGoogle Scholar
  34. NTP (1986) Toxicology and carcinogenesis study of marine diesel fuel and JP-5 Navy Fuel in B6C3F1 Mice (Dermal Studies). Technical Report 310. NIH Publication no. 86–2566. Research Triangle Park. National Toxicology Program, North CarolinaGoogle Scholar
  35. Pleil JD, Smith LB, Zelnick SD (2000) Personal exposure to JP-8 jet fuel vapors and exhaust at air bases. Environ Health Perspect 108:183–192CrossRefGoogle Scholar
  36. Richards DE, Begley KB, DeBord DG, Cheever KL, Weigel WW, Tirmenstein MA, Savage RE (1993) Comparative metabolism of bis(2-methoxethyl)ether in isolated rat hepatocytes and in the intact rat–effects of ethanol on in vitro metabolism. Arch Toxicol 67:531–537CrossRefGoogle Scholar
  37. Ritchie GD, Still KR, Rossi J, Bekkedal MYV, Boff AJ, Arfsten DP (2003) Biological and health effects of exposure to kerosene-based jet fuels and performance additives. J Toxicol Environ Health Part B 6:357–451CrossRefGoogle Scholar
  38. Schultz TW, Eppler JL, Witschi H (1981) Health effects research in oil shale development. Oak Ridge National Laboratory, Oak Ridge, Tennessee, ORNL/TM-8034Google Scholar
  39. Serdar B, Egeghy PP, Waidyanatha S, Gibson R, Rappaport SM (2003) Urinary biomarkers of exposure to jet fuel (JP-8). Environ Health Perspect 111:1760–1764CrossRefGoogle Scholar
  40. Serdar B, Egeghy PP, Gibson R, Rappaport SM (2004) Dose-dependent production of urinary naphthols among workers exposed to jet fuel (JP-8). Am J Ind Med 46:234–244CrossRefGoogle Scholar
  41. Smith LB, Bhattacharya A, Lemasters G, Succop P, Puhala E, Medvedovic M, Joyce J (1997) Effect of chronic low-level exposure to jet fuel on postural balance of U.S. Air Force personnel. J Occup Environ Med 39:623–632CrossRefGoogle Scholar
  42. Smith KW, Proctor SP, Ozonoff A, McClean MD (2010) Inhalation exposure to jet fuel (JP-8) among U.S. Air Force personnel. J Occup Environ Hyg 7:563–572CrossRefGoogle Scholar
  43. Sumner SC, Stedman DB, Clarke DO, Welch F, Fennell TR (1992) Characterization of urinary metabolites from [1, 2-methoxyl-13C]-2-methoxyethanol in mice using 13C nuclear magnetic resonance spectroscopy. Chem Res Toxicol 5:553–560CrossRefGoogle Scholar
  44. Vere RA (2003) Aviation fuels. In: Hobson GD (ed) Modern petroleum technology, part 2. Wiley, Chinchester, pp 723–771Google Scholar
  45. Zeiger E, Smith L (1998) The first international conference on the environmental health and safety of jet fuel. Environ Health Perspect 106:763–764CrossRefGoogle Scholar

Copyright information

© Springer-Verlag (outside the USA) 2011

Authors and Affiliations

  • Clayton B’Hymer
    • 1
  • Patricia Mathias
    • 1
  • Edward KriegJr.
    • 1
  • Kenneth L. Cheever
    • 1
  • Christine A. Toennis
    • 1
  • John C. Clark
    • 1
  • James S. Kesner
    • 1
  • Roger L. Gibson
    • 2
  • Mary Ann Butler
    • 1
  1. 1.U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and HealthDivision of Applied Research and Technology, Taft LaboratoryCincinnatiUSA
  2. 2.Preventive Medicine and Biometric DepartmentUniform Services UniversityBethesdaUSA

Personalised recommendations